Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk Prediction for Liver Cancer”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableNot Yet RecruitingNCT06356623
What this trial is testing

A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer

Who this might be right for
Nausea and Vomiting, PostoperativeLiver Cancer
Shanghai Zhongshan Hospital 476
Not applicableNot Yet RecruitingNCT06778317
What this trial is testing

MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients with Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)CirrhosisRisk Prediction for Liver Cancer+1 more
Central Hospital, Nancy, France 400
Not applicableActive Not RecruitingNCT06699524
What this trial is testing

Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid

Who this might be right for
Hepatocellular Carcinoma
Shen Feng 122
Not applicableStudy completedNCT02113865
What this trial is testing

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

Who this might be right for
Acquired Immunodeficiency Syndrome VirusHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHepatocellular Carcinoma
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 45
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Not applicableNot Yet RecruitingNCT07320755
What this trial is testing

Analysis of Computed Tomography Derived Maps for Determining Changes of the Liver Volume After Exposure to Radiotherapy

Who this might be right for
Intra-abdominal MalignanciesLiver as Organ at RiskRadiation-related Liver Changes
Assiut University 70
Not applicableStudy completedNCT06799468
What this trial is testing

Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma (HCC)Liver TransplantationDeep Learning Model
European Hepatocellular Cancer Liver Transplant Group 1,769
Not applicableActive Not RecruitingNCT06325826
What this trial is testing

The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs

Who this might be right for
Hepatocellular Carcinoma
Egyptian Liver Hospital 500